BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 32694945)

  • 1. Long non-coding RNA NORAD exhaustion represses prostate cancer progression through inhibiting TRIP13 expression via competitively binding to miR-495-3p.
    Chen F; Liu L; Wang S
    Cancer Cell Int; 2020; 20():323. PubMed ID: 32694945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNA-non-coding RNA activated by DNA damage inhibition suppresses hepatic stellate cell activation via microRNA-495-3p/sphingosine 1-phosphate receptor 3 axis.
    Zou L; Shi C; Wang D; Cheng J; Wang Q; Wang L; Yang G
    Bioengineered; 2022 Mar; 13(3):6150-6162. PubMed ID: 35200103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA NORAD accelerates the progression and doxorubicin resistance of neuroblastoma through up-regulating HDAC8 via sponging miR-144-3p.
    Wang B; Xu L; Zhang J; Cheng X; Xu Q; Wang J; Mao F
    Biomed Pharmacother; 2020 Sep; 129():110268. PubMed ID: 32563146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of lncRNA ZEB1-AS1 Represses Cell Proliferation, Migration, and Invasion Through Mediating PI3K/AKT/mTOR Signaling by miR-342-3p/CUL4B Axis in Prostate Cancer.
    Ma T; Chen H; Wang P; Yang N; Bao J
    Cancer Biother Radiopharm; 2020 Nov; 35(9):661-672. PubMed ID: 32275162
    [No Abstract]   [Full Text] [Related]  

  • 5. Propofol Ameliorates the Proliferation and Epithelial-Mesenchymal Transition of Hepatoma Carcinoma Cells via Non-Coding RNA Activated by DNA Damage (NORAD)/microRNA (miR)-556-3p/Migration and Invasion Enhancer 1 (MIEN1) Axis.
    Liu Y; Wang X; Li H; Guan E; Luo K
    J Environ Pathol Toxicol Oncol; 2021; 40(4):87-97. PubMed ID: 34936303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA NORAD contributes to the proliferation, invasion and EMT progression of prostate cancer via the miR-30a-5p/RAB11A/WNT/β-catenin pathway.
    Zhang Y; Li Y
    Cancer Cell Int; 2020 Nov; 20(1):571. PubMed ID: 33292272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNA NORAD inhibition upregulates microRNA-323a-3p to suppress tumorigenesis and development of breast cancer through the PUM1/eIF2 axis.
    Shi P; Zhang J; Li X; Li W; Li H; Fu P
    Cell Cycle; 2021 Jul; 20(13):1295-1307. PubMed ID: 34125645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding TUG1 accelerates prostate cancer progression through regulating miR-128-3p/YES1 axis.
    Hao SD; Ma JX; Liu Y; Liu PJ; Qin Y
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):619-632. PubMed ID: 32016963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA XIST expedites lung adenocarcinoma progression through upregulating MDM2 expression via binding to miR-363-3p.
    Rong H; Chen B; Wei X; Peng J; Ma K; Duan S; He J
    Thorac Cancer; 2020 Mar; 11(3):659-671. PubMed ID: 31968395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNA NORAD promotes the prostate cancer cell extracellular vesicle release via microRNA-541-3p-regulated PKM2 to induce bone metastasis of prostate cancer.
    Hu CY; Chen J; Qin XH; You P; Ma J; Zhang J; Zhang H; Xu JD
    J Exp Clin Cancer Res; 2021 Mar; 40(1):98. PubMed ID: 33722248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circ_0062020 Knockdown Strengthens the Radiosensitivity of Prostate Cancer Cells.
    Li H; Zhi Y; Ma C; Shen Q; Sun F; Cai C
    Cancer Manag Res; 2020; 12():11701-11712. PubMed ID: 33235500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circular RNA RBM33 contributes to cervical cancer progression via modulation of the miR-758-3p/PUM2 axis.
    Ding Y; Yuan X; Gu W
    J Mol Histol; 2021 Apr; 52(2):173-185. PubMed ID: 33398465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA (LncRNA) non-coding RNA activated by DNA damage (NORAD) knockdown alleviates airway remodeling in asthma via regulating miR-410-3p/RCC2 and inhibiting Wnt/β-catenin pathway.
    Zhang T; Huang H; Liang L; Lu H; Liang D
    Heliyon; 2024 Jan; 10(1):e23860. PubMed ID: 38261955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of long non-coding RNA NORAD promotes invasion and migration in malignant melanoma via regulating the MIR-205-EGLN2 pathway.
    Chen Y; Cao K; Li J; Wang A; Sun L; Tang J; Xiong W; Zhou X; Chen X; Zhou J; Liu Y
    Cancer Med; 2019 Apr; 8(4):1744-1754. PubMed ID: 30843652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNA NORAD regulates lung cancer cell proliferation, apoptosis, migration, and invasion by the miR-30a-5p/ADAM19 axis.
    Li J; Xu X; Wei C; Liu L; Wang T
    Int J Clin Exp Pathol; 2020; 13(1):1-13. PubMed ID: 32055266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulatory mechanism of lncRNA NORAD on proliferation and invasion of ovarian cancer cells through miR-199a-3p.
    Xu C; Zhu LX; Sun DM; Yao H; Han DX
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1672-1681. PubMed ID: 32141533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA NORAD/miR-224-3p/MTDH axis contributes to CDDP resistance of esophageal squamous cell carcinoma by promoting nuclear accumulation of β-catenin.
    Jia Y; Tian C; Wang H; Yu F; Lv W; Duan Y; Cheng Z; Wang X; Wang Y; Liu T; Wang J; Liu L
    Mol Cancer; 2021 Dec; 20(1):162. PubMed ID: 34893064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNA KCNQ1OT1 up-regulates CTNND1 by sponging miR-329-3p to induce the proliferation, migration, invasion, and inhibit apoptosis of colorectal cancer cells.
    Liu X; Zhang Y; Wang Y; Bian C; Wang F
    Cancer Cell Int; 2020; 20():340. PubMed ID: 32760218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hsa_circRNA_100146 Promotes Prostate Cancer Progression by Upregulating TRIP13
    Zeng L; Liu YM; Yang N; Zhang T; Xie H
    Front Mol Biosci; 2021; 8():693477. PubMed ID: 34307457
    [No Abstract]   [Full Text] [Related]  

  • 20. lncRNA NORAD promotes lung cancer progression by competitively binding to miR-28-3p with E2F2.
    Mao W; Wang S; Chen R; He Y; Lu R; Zheng M
    Open Med (Wars); 2022; 17(1):1538-1549. PubMed ID: 36245705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.